Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages

Lei Deng1, Lorena Itatí Ibañez1, Veronique Van den Bossche1

  • 1Medical Biotechnology Center, VIB, Technologiepark 927, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Technologiepark 927, Ghent, Belgium.

Plos One
|May 15, 2015
PubMed

Insights

Researchers developed a novel universal influenza A vaccine using bacteriophage carriers displaying a conserved M2e epitope. This economical approach successfully immunized mice, offering protection against both human and avian influenza A virus strains.

Area of Science:

  • Virology
  • Immunology
  • Biotechnology

Background:

  • Influenza A viruses cause global epidemics and pandemics, necessitating effective vaccines.
  • The extracellular domain of Matrix protein 2 (M2e) is a conserved target for a universal influenza A vaccine.
  • Current vaccine development faces challenges in cost and purification.

Purpose of the Study:

  • To create an economical and easily purified M2e-based universal influenza A vaccine.
  • To utilize filamentous bacteriophages as carriers for displaying M2e epitopes.

Main Methods:

  • Genetically fused M2e (amino acids 2-16) to the N-terminus of bacteriophage f88's pVIII coat protein.
  • Produced replication-competent recombinant f88-M2e2-16 phages displaying M2e on their surface.
  • Immunized BALB/c mice with purified f88-M2e2-16 phages and incomplete Freund's adjuvant.

Main Results:

  • Recombinant f88-M2e2-16 phages were replication competent and successfully displayed the M2e epitope.
  • Immunization induced robust M2e-specific serum IgG responses in mice.
  • Vaccinated mice were protected against challenge with both human and avian influenza A viruses.

Conclusions:

  • Replication-competent filamentous bacteriophages are effective and economical carriers for displaying conserved influenza A B cell epitopes.
  • This phage-based platform shows promise for developing a universal influenza A vaccine.

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.5K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.9K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.8K